Hypokalemic periodic paralysis due to Graves Disease.
Drakaki
Alexandra
A
Habib
Muzzamal
M
Sweeney
Ann T
AT
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D001007:Anxiety / Q000209:etiology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology; D004417:Dyspnea / Q000209:etiology; D006111:Graves Disease / Q000150:complications* / Q000175:diagnosis; D006801:Humans; D020514:Hypokalemic Periodic Paralysis / Q000188:drug therapy / Q000209:etiology*; D008296:Malaysia / Q000208:ethnology; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D018908:Muscle Weakness / Q000209:etiology; D009460:Neurologic Examination; D011188:Potassium / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011441:Propylthiouracil / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000209:etiology; D014202:Tremor / Q000209:etiology; D015431:Weight Loss
D000889:Anti-Arrhythmia Agents; D013956:Antithyroid Agents; D008713:Methimazole; D011441:Propylthiouracil; D011433:Propranolol; D011188:Potassium